Relaxed DM requirements during class II peptide loading and CD4+ T cell maturation in BALB/c mice

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 5087-5098

  Bikoff, E K ^a   Wutz, G ^a   Kenty, G A ^a   Koonce, C H ^a   Robertson, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DM ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0035871801     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.5087     Document Type: Article

References (72)

1. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
2. Structures of an MHC class II molecule with covalently bound single peptides
3. k in complex with a dominant epitope of lysozyme
4. d-peptide complexes reveal that high affinity can be achieved without large anchor residues
5. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
6. Developing and shedding inhibitions: How MHC class II molecules reach maturity
7. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules
8. Association between HLA-DM and HLA-DR in vivo
9. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH
10. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly
11. Binding of major histocompatibility complex class II to the invariant chain derived peptide, CLIP, is regulated by allelic polymorphism in class II
12. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules
13. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner
14. A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules
15. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: Rapid release of CLIP at an endosomal pH
16. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
17. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms
18. k class II molecules in human APC containing deleted or mutated HLA DM genes
19. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent
20. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules
21. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines
22. H2-M mutant mice are defective in the peptide loading of class II molecules antigen presentation, and T cell repertoire selection
23. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway
24. Antigen presentation and T cell development in H2-M-deficient mice
25. + T cells in mice displaying altered repertoires of MHC class II-bound self-peptides
26. + T cells
27. + T cells in H-2Ma0/0 mice
28. Requirement for diverse, low-abundance peptides in positive selection of T cells
29. The influence of invariant chain on the positive selection of single T cell receptor specificities
30. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed
31. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line
32. Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci
33. + T cell selection in mice lacking invariant chain expression
34. + T cells in the periphery and secondary proliferative responses elicited upon peptide challenge
35. New class II-like genes in the murine MHC
36. The assignment of chain specifities for anti-Ia monoclonal antibodies using L cell transfectants
37. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules: Implications for Ia function and evolution
38. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes
39. MHC class II expression in double mutant mice lacking invariant chain and DM functions
40. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1
41. Mice lacking the MHC class II-associated invariant chain
42. Mouse endogenous superantigens: Mls and Mls-like determinants encoded by mouse retroviruses
43. DM determines the cryptic and immunodominant fate of T cell epitopes
44. 2-microglobulin to class II-restricted T cells leads to self-tolerance
45. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces
46. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding
47. d
48. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules
49. Formation of a highly peptide-receptive state of class II MHC
50. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides
51. Abundant empty class II MHC molecules on the surface of immature dendritic cells
52. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain
53. Class II major histocompatibility complex molecules of murine dendritic cells; synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture
54. Dendritic cell maturation and antigen presentation in the absence of invariant chain
55. Sequence analysis of peptides bound to MHC class II molecules
56. Self release of CLIP in peptide loading of HLA-DR molecules
57. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
58. Interaction of MHC class II molecules with the invariant chain: Role of the invariant chain (81-90) region
59. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1
60. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules
61. Processing and major histocompatibility complex binding of the MTV7 superantigen
62. Proteolytic processing is required for viral superantigen activity
63. Toxic MHC class II β chains
64. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport
65. Negative regulation by HLA-DO of MHC class II-restricted antigen processing
66. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules
67. Altered antigen presentation in mice lacking H2-O
68. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO
69. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells
70. Crystal structure of mouse H2-M
71. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation
72. Determination of the HLA-DM interaction site on HLA-DR molecules